William Riedl

Scientist at NeuBase Therapeutics - Pittsburgh, PA, US

William Riedl's Contact Details
HQ
N/A
Location
Pittsburgh, Pennsylvania, United States
Company
NeuBase Therapeutics
William Riedl's Company Details
NeuBase Therapeutics logo, NeuBase Therapeutics contact details

NeuBase Therapeutics

Pittsburgh, PA, US • 50 - 99 Employees
Major Drugs

NeuBase is developing ultra precision genetic medicines targeting rare, monogenic diseases, for which there are no approved therapies, as well as more common genetic disorders, including cancers that are resistant to current therapeutic approaches. NeuBase's pipeline includes therapeutic candidates for the treatment of myotonic dystrophy type 1 (DM1), Huntington's disease (HD), and cancer-driving point mutations in KRAS G12V and G12D, which are involved in many tumor types and have historically been "undruggable."

Biotechnology Gene Silencing Antisense Oligonucleotide Therapies Rare Disease Genetic Disease Huntington's Disease Myotonic Dystrophy CNS Disease Huntington's Disease
Details about NeuBase Therapeutics
Frequently Asked Questions about William Riedl
William Riedl currently works for NeuBase Therapeutics.
William Riedl's role at NeuBase Therapeutics is Scientist.
William Riedl's email address is ***@neubasetherapeutics.com. To view William Riedl's full email address, please signup to ConnectPlex.
William Riedl works in the Major Drugs industry.
William Riedl's colleagues at NeuBase Therapeutics are Eunah Cho, Bridget Sawyer-Revels, Thomas Zengeya, Valentina Caro, Mykaela Wagner, Matthew Koch, James Burrows and others.
William Riedl's phone number is N/A
See more information about William Riedl